Portfolio company
Intero Biosystems
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops human intestinal organoid platforms for pharmaceutical and biotechnology firms to replace animal testing in preclinical drug discovery and safety assessment.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hesperos
This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
VitrofluidiX
VitrofluidiX develops an integrated organ-on-a-chip platform for pharmaceutical companies and research institutions to conduct predictive human biology testing without animal models.
Cytochroma
This company manufactures genetically diverse stem cell-derived mini-organs to provide animal-free drug safety and efficacy testing for pharmaceutical and biotechnology organisations.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
RadaHaim
This company provides scalable organoid mass production platforms and research services to pharmaceutical firms and clinicians for drug discovery and toxicity screening.
